Renal branching morphogenesis, defined as growth and branching of the ureteric bud (UB), is a tightly regulated process controlled by growth factor-dependent tissue interactions. Previously, using in vitro models of branching morphogenesis, we demonstrated that BMP2 signals via its intracellular effectors, SMAD1 and SMAD4, to control UB cell proliferation and branching in a manner modulated by Glypican-3 (GPC3), a cell surface heparan sulfate proteoglycan. Here, we used loss-of-function genetic mouse models to investigate the functions of Bmp2 and Gpc3-Bmp2 interactions in vivo. Progressively greater increases in UB cell proliferation were observed in Bmp2C/K, Smad4C/K, and Bmp2C/K; Smad4C/K mice compared to Wt. This increased cell proliferation was accompanied by a significant increase in UB branching in Smad4C/K and Bmp2C/K;Smad4C/K mice compared to Wt. Reduction of Gpc3 gene dosage also increased UB cell proliferation, an effect that was enhanced in Gpc3C/K;Bmp2C/K mice to an extent greater than the sum of that observed in Gpc3C/K and Bmp2C/K mice. Reduction of both Gpc3 and Bmp2 gene dosage enhanced cell proliferation in the metanephric mesenchyme compared to Wt, an effect not observed in either Bmp2C/K or Gpc3C/K mice. Phosphorylation of SMAD1, a measure of SMAD1 activation, was progressively decreased in Gpc3C/K and Gpc3C/K;Bmp2C/K mice compared to Wt, suggesting that Gpc3 stimulates Bmp2-dependent SMAD signaling in vivo. These results demonstrate that BMP2-SMAD signaling, modulated by GPC3, inhibits renal branching morphogenesis in vivo. q
Introduction
Branching morphogenesis, defined as growth and branching of epithelial tubules during embryonic development, is fundamental to the development of many essential organs, including the mammalian kidney, lung, mammary gland, salivary glands, pancreas and seminiferous tubules, as well as the larval tracheal system in Drosophila [reviewed in (Davies and Fisher, 2002) ]. In embryonic tissues, growth and branching of epithelial tubules is a highly coordinated process, regulated by both stimulatory and inhibitory pathways which signal between the branching tubules and surrounding mesenchyme [reviewed in (Shah et al., 2004) ]. Renal branching morphogenesis is dependent upon reciprocal inductive interactions between the metanephric blastema, a mesenchymal tissue, and the epithelium-derived ureteric bud (UB). The collecting duct system of the kidney arises through the outgrowth and repeated branching of the UB and its daughter collecting duct cells (Potter, 1972; Saxen, 1987) . UB growth and branching is preceded by highly localized increases in cell Mechanisms of Development 122 (2005) proliferation at the UB tips suggesting that cell proliferation is an important morphogenetic mechanism controlling branching morphogenesis in vivo (Michael and Davies, 2004) . Glypican 3 (GPC3), a glycosyl phosphatidyl inositol (GPI)-linked heparan sulfate proteoglycan (HSPG), is essential for normal renal branching morphogenesis in vivo. Gpc3 transcripts are expressed in both the mesenchymal and UB-derived tissue elements during embryonic renal development (Grisaru et al., 2001) . In humans, mutations in Gpc3 cause the X-linked overgrowth disease Simpson-Golabi-Behmel Syndrome, characterized in part by pre-and post-natal somatic overgrowth, and renal medullary cystic dysplasia (Pilia et al., 1996; Neri et al., 1998; Cano-Gauci et al., 1999) . In mice, mutational inactivation of Gpc3 causes renal medullary cystic dysplasia characterized by a reduction in the number of medullary collecting ducts, cystic malformation of medullary collecting ducts, and an increase in medullary interstitial extracellular matrix (Cano-Gauci et al., 1999) . The appearance of these histopathologic abnormalities is preceded by selective overgrowth of the UB that is associated with a marked increase in UB cell proliferation (Grisaru et al., 2001) , suggesting that abnormal regulation of UB cell proliferation contributes to the medullary dysplasia in Gpc3 null mice.
Bone morphogenetic proteins (BMPs) belong to the TGF-b superfamily, a group of heparin-binding secreted growth factors that regulate cell proliferation, differentiation and organ development in many tissues including the kidney (Piscione et al., 1997; Miyazaki et al., 2000; Cain et al., 2005) . Genetic glypican-Bmp interactions control development of non-renal tissues in flies (dally-decapentaplegic) and in mice (Jackson et al., 1997; Paine-Saunders et al., 2000; Fujise et al., 2003) . In mice, Bmp2 transcripts are expressed in condensed mesenchyme adjacent to the tips of the branching UB, consistent with a role for Bmp2 in controlling cell proliferation and branching of the growing UB (Dudley and Robertson, 1997) . However, homozygous deletion of Bmp2 is early embryonic lethal, precluding analysis of the renal phenotype in these mice, while histologic analysis of Bmp2C/K heterozygote mice has been reported as normal (Zhang and Bradley, 1996) . Thus, analysis of Bmp2 mutant mice has not facilitated attempts to define the role of the Bmp2 signaling axis in mouse kidney development. Recently, we demonstrated that a Bmp2-Smad1 dependent signaling pathway inhibits UB branch formation and cell proliferation in isolated embryonic kidney explants and in the mIMCD3 culture model of collecting duct cell morphogenesis (Piscione et al., 1997 (Piscione et al., , 2001 Gupta et al., 1999) . While we have demonstrated that this inhibitory Bmp2 pathway is regulated by Gpc3 in these in vitro models, genetic Bmp2-Gpc3 interactions have not been identified during kidney development in vivo.
In this work, we investigated the function of the inhibitory Bmp2 signaling axis and genetic Bmp2-Gpc3 interactions during renal development in vivo. We performed a high-resolution analysis of branch formation and cell proliferation during branching morphogenesis in vivo. Bmp2 haploinsufficiency exerted no detectable effect on branch point formation. However, UB cell proliferation was increased in both Bmp2C/K and Gpc3C/K mice. A marked increase in UB cell proliferation greater than the sum of that detected in either Gpc3C/K or Bmp2C/K mice was observed in Gpc3C/K;Bmp2C/K mutants. Gpc3C/K;Bmp2C/K mice also exhibited increased mesenchymal cell proliferation, a defect not observed in either Gpc3C/K or Bmp2C/K mice. Our finding of decreased expression of phospho-SMAD1, an intracellular effector of BMP2, in Gpc3C/K;Bmp2C/K mice demonstrates that GPC3 modulates the activity of the BMP2 signaling pathway. Taken together, our results demonstrate that Bmp2 and Gpc3 interact to control renal development in vivo.
Results and discussion

The inhibitory Bmp2 signaling axis controls renal branching morphogenesis in vivo
We previously showed that exogenous BMP2 inhibits UB cell proliferation and branching in cultured kidney explants, and in the mIMCD-3 culture model of collecting duct cell morphogenesis (Piscione et al., 1997) . Consistent with these observations, BMP2-mediated inhibition is decreased in collecting duct cells expressing mutant lossof-function forms of the type I BMP2 receptor, ALK3 (Gupta et al., 2000; Piscione et al., 2001) , or the intracellular BMP2 effector, SMAD1 (Gupta et al., 1999; Piscione et al., 2001) . Taken together, these results implicate the inhibitory Bmp2 signaling pathway in the control of embryonic renal development in vivo.
We examined Bmp2 function in vivo by performing a high resolution analysis of UB branch point formation in mice heterozygous null for Bmp2 or for its downstream effector Smad4, and in Bmp2C/K;Smad4C/K mice ( Fig. 1) . At E13.5, renal branching morphogenesis is well established and discrete branch points can be identified using the UB-specific marker DBA (Piscione et al., 1997) . Despite a histologic normal phenotype (data not shown), quantitation of UB branch points demonstrated a 12% increase in UB branches in Smad4C/K mutants compared to Wt (PZ0.01) (Fig. 1, Table 1 ). The increase in branch point formation in Smad4C/K mutants is consistent with the role of Smad4 as the common mediator of both inhibitory TGF-b and BMP signaling during renal development (Shi and Massague, 2003) . To determine a specific role of Bmp2 in renal branching morphogenesis, we examined branch point formation in Bmp2C/K mice. Bmp2 haploinsufficiency alone had no significant effect on UB branching (PZ0.59). However, branch point number increased by approximately 25% in Bmp2C/K; Smad4C/K mutants compared to Wt (PZ0.002) and compared to Bmp2C/K (PZ0.001) mice. Branch point number in Bmp2C/K;Smad4C/K mice was also 12% greater than in Smad4C/K mice. However, the difference in the number of branches formed was not significant (PZ 0.21), due to the high variability in branch point number particularly in Smad4C/K and Bmp2C/K;Smad4C/K mice.
Localized bursts of cell proliferation at the tips of the growing UB precede branching events throughout renal development, and may represent an important morphogenetic mechanism controlling branching morphogenesis. Consistent with this hypothesis, changes in UB morphogenesis in response to exogenous chemicals (e.g. sodium chlorate) or growth factors (e.g. GDNF, TGF-b) are first detected at the level of cell proliferation, before and even without observable alterations in branching in isolated kidney explants (Michael and Davies, 2004) . These results suggest that measuring cell proliferation could be a more sensitive measure of genetic interactions. Therefore, we investigated the in vivo role of the inhibitory Bmp2 signaling axis by examining the effects of varying Bmp2 and/or Smad4 gene dosage on UB cell proliferation in E13.5 paraffin-embedded tissue sections, using an in situ BrDU incorporation assay ( Fig. 2A) . UB cell proliferation was calculated as the ratio of BrDU-positive UB cells to total number of UB cells. Our results demonstrated a significant increase in UB cell proliferation in all three genetically distinct groups compared to Wt (Table 2, Fig. 2B ). While Bmp2C/K mutants had not exhibited a significant increase in branch point formation, our results demonstrated a 38% increase in UB cell proliferation in Bmp2C/K kidneys compared to Wt (PZ0.03). Even greater increases in UB cell proliferation were observed in Smad4C/K mice, with an increase of 270% compared to Wt (PZ0.003) and an increase of 235% compared to Bmp2C/K mutants (PZ 0.008). However, the greatest increase in UB cell proliferation was observed in Bmp2C/K;Smad4C/K mutants compared to Wt (411% increase, PZ0.002). Notably, the increase in UB cell proliferation in Bmp2C/K;Smad4C/K mutants was significantly higher than either Bmp2C/K (372% increase, PZ0.01) or Smad4C/K (137% increase, PZ0.04) single mutants. Together, these results demonstrate that Bmp2 inhibits cell proliferation of the UB, and are consistent with the established role of inhibitory Bmp2-Smad4 signaling in the control of branching morphogenesis in vitro (Piscione et al., 2001) . Notably, our results demonstrate that marked increases in UB cell proliferation in Bmp2C/K;Smad4C/K kidneys are associated with only a moderate increase in branch number, while the milder increases in UB cell proliferation in Bmp2C/K kidneys do not result in a detectable change in branch formation. These results suggest that branch formation is relatively impervious to moderate fluxes in cell proliferation, and that a threshold must be reached before changes Bmp2 and/or Smad4 gene dosage on branch formation in E13.5 embryonic mouse kidney explants. Embryonic kidney explants were fixed, stained with DBA to identify UB/collecting duct branches, and imaged by fluorescence microscopy. Branch formation was not altered in Bmp2C/K explants, but was enhanced in the Smad4C/K and Bmp2C/K ;Smad4C/K background compared to Wt. Magnification: 100!. Bar: 100 mm. (B) Quantitation of Bmp2 and/or Smad4 gene dosage effects on branch points in E13.5 embryonic kidneys. The number of branch points was measured and expressed as -fold change vs. Wt. Branch point formation was not altered in the Bmp2C/K background (-fold increase, Bmp2C/K vs. Wt: 0.963G0.05, NZ18, PZ0.59), but was significantly increased in Smad4C/K explants (-fold increase, Smad4C/K vs. Wt: 1.12G0.06, NZ 24, PZ0.01) compared to Wt. Branch point formation was further increased in Bmp2C/K; Smad4C/K explants compared to both Wt and Bmp2C/K explants (-fold increase, Bmp2C/K;Smad4C/K vs. Wt: 1.25G0.07, NZ14, PZ0.002, Bmp2C/K;Smad4C/K vs. Bmp2C/K: 1.28G0.06, PZ0.001). NZnumber of kidney explants assessed. in UB cell proliferation can effect changes in branch point number.
Inspection of BrDU-labeled kidney tissue sections demonstrated a moderate enlargement of Smad4C/K and Bmp2C/K: Smad4C/K kidneys compared to both Wt and Bmp2C/K groups but not to each other, and an apparent increase in mesenchymal cell proliferation. We evaluated the effects of varying Bmp2 and/or Smad4 gene dosage on mesenchymal cell proliferation to determine if these increases were statistically significant (Fig. 2C) . Mesenchymal cell proliferation was quantitated as the ratio of BrDUpositive cells, DBA-negative cells to total kidney surface area. In a given kidney sample, the total number of BrDUpositive mesenchymal cells counted ranged from 759 to 2622 cells (mean:1522.53G135.46 BrDU-positive cells per sample). Our results demonstrate that mesenchymal cell proliferation was unchanged in Bmp2C/K mutants compared to Wt (PZ0.55). However, in Smad4C/K mutants, mesenchymal cell proliferation was increased by 31% compared to Wt (PZ0.02) and 27% compared to Bmp2C/K mutants (PZ0.04). In Bmp2C/K;Smad4C/K mutants, mesenchymal cell proliferation was increased by 33% compared to Wt (PZ0.01), and by 30% compared to Bmp2C/K mutants (PZ0.02). Mesenchymal cell proliferation was not different between Smad4C/K and Bmp2C/K;Smad4C/K groups (PZ0.82). Taken together, our results demonstrate that the Bmp2-Smad signaling axis inhibits UB and mesenchymal cell proliferation during renal development in vivo.
Recently, Oxburgh et al. showed that conditional deletion of Smad4 in the UB lineage alone does not result in a histologic phenotype during embryonic renal development, leading the authors to conclude that Smad4 does not contribute to development of the collecting duct system (Oxburgh et al., 2004) . While our histologic analysis of Smad4C/K kidneys yielded identical results to those of Oxburgh et al., our analysis of branch point formation and cell proliferation in these mice demonstrated marked increases in both. The finding of a normal histology in Smad4C/K kidneys despite these increases suggests that modest increases in UB branch number are not detectable by histologic analysis alone. Oxburgh et al. also demonstrate that deletion of Smad4 in both the UB and mesenchymal elements of the developing kidney (UB-mesenchymeSmad4 nulls) results in major disruptions in both the size and organization of the nephrogenic mesenchyme, and causes a mild decrease in the number of collecting ducts at E12 and a further decrease at E14.5. The diminished UB number and overall kidney size observed in UB-mesenchyme-Smad4-nulls may reflect deleterious secondary effects Dark red-colored nuclei are BrDU-positive. Arrows denote the UB. UB cell proliferation was progressively increased in Bmp2C/K, Smad4C/K and Bmp2C/K;Smad4C/K kidney explants compared to Wt. Magnification: 400!. Bar: 50 mm. (B) Quantitation of Bmp2 and/or Smad4 gene dosage on UB cell proliferation. UB cell proliferation was expressed as -fold increase vs. Wt. UB cell proliferation was progressively increased in the Bmp2C/K , Smad4C/K and Bmp2C/K;Smad4C/K background compared to Wt (-fold increase, Bmp2C/K vs. Wt: 1.38G0.16, NZ7, PZ0.03, Smad4C/K vs. Wt: 3.74G0.36, NZ10, PZ0.003, Bmp2C/K; Smad4C/K vs. Wt: 5.11G0.48, NZ5, PZ0.002). UB cell proliferation was also significantly different between groups (-fold increase, Bmp2C/K; Smad4C/K vs. Bmp2C/K: 3.72G0.38, PZ0.01, Bmp2C/K; Smad4C/K vs. Smad4C/K: 1.37G0.14, PZ0.04, Smad4C/K vs. Bmp2C/K: 2.35G 0.26, PZ0.008). NZnumber of complete kidney composites assessed. (C) Quantitation of the effect of Bmp2 and/or Smad4 gene dosage on mesenchymal cell proliferation. Mesenchymal cell proliferation was unchanged in Bmp2C/K mutants compared to Wt, but was increased in Smad4C/K and Bmp2C/K;Smad4C/K mutants compared to Wt (-fold increase: Smad4C/K vs. Wt: 1.31G0.11, PZ0.02, Bmp2C/K;Smad4C /K vs. Wt: 1.33G0.08, PZ0.01) and to Bmp2C/K single mutants (-fold increase: Smad4C/K vs. Bmp2C/K: 1.27G0.12, PZ0.04, Bmp2C/K; Smad4C/K vs. Bmp2C/K: 1.30G0.10, PZ0.02). related to the diminished capacity of mesenchymal inducing factors to stimulate branching and growth, in addition to any primary effects due to decreased Smad4 gene dosage alone. In contrast, the Bmp2C/K and Smad4C/K haploinsufficiency models studied here and characterized by intact glomerulogenesis, are distinct from the model of Oxburgh et al. in which a more complete deletion of Smad4 was generated in either the UB alone or in both the UB and metanephric mesenchyme. In this respect, the absence of major disruptions in the mesenchyme or UB compartments of our mutant mouse models facilitated our attempts to identify the primary functions of Bmp2 and Gpc3 on discrete aspects of renal development.
Genetic Gpc3-Bmp2 interactions control ureteric bud and mesenchymal cell proliferation during renal development
Genetic glypican-Bmp interactions control non-renal development in flies (Jackson et al., 1997; Fujise et al., 2003) and in mice (Paine-Saunders et al., 2000) . Previously, we showed that Gpc3 inhibits UB cell proliferation during renal development in vivo, and that inhibition of branching by BMP2 is abrogated in cultured embryonic kidney explants isolated from male mice with a mutant Gpc3 allele (Grisaru et al., 2001) . The genotype of these mice is Gpc3K/ since Gpc3 is encoded on the X chromosome (Pilia et al., 1996) . Because the changes we observed in UB cell proliferation in response to varying Bmp2 and Smad4 gene dosage far exceeded those in branch point formation, we considered UB cell proliferation to be a more robust and sensitive measure of genetic interactions during embryonic renal development. We investigated genetic Gpc3-Bmp2 interactions during renal branching morphogenesis in vivo by measuring the gene dosage effects of Gpc3 and Bmp2 in the context of UB cell proliferation.
Gpc3C/K females are characterized by low rates of fertility and small litter sizes (median litter sizeZ7). The expected frequency of male Gpc3K/, male Gpc3K/;Bmp2C/K, female Gpc3C/K and female Gpc3C/K;Bmp2C/K offspring generated from crosses between Gpc3C/K and Bmp2C/K mice is 1/8. However, in actual fact, the number of male Gpc3K/ and male Gpc3K/;Bmp2C/K embryos obtained was far less than expected (Gpc3K/Z4/53 embryos, Gpc3K/;Bmp2C/KZ 1/53 embryos). The failure to generate more than one male Gpc3K/; Bmp2C/K embryo suggests that an early embryonic lethality is associated with this genotype and precluded analysis of Gpc3-Bmp2 interactions in males. In contrast, the number of female Gpc3C/K and female Gpc3C/K;Bmp2C/K offspring generated was consistent with that predicted, thereby facilitating our analysis of Gpc3-Bmp2 interactions in females (Gpc3C/KZ7/53 embryos; Gpc3C/K;Bmp2C/KZ6/53 embryos). To investigate the possibility that branching morphogenesis is differentially regulated in males vs. females, we compared branch point number in kidneys isolated from E13.5 male and female Wt and Bmp2C/K mice. We did not detect any significant difference between males and females (branch point number, male vs. female: Bmp2C/K, 89.2G7.8 vs. 95.1G11.2, PZ0.66; Wt, 94.0G5.8 vs. 98.1G7.1, PZ 0.74). Therefore, we investigated genetic Gpc3-Bmp2 interactions in a female Gpc3C/K background.
As a first step towards investigating genetic interactions between Gpc3 and Bmp2, we confirmed that GPC3 and BMP2 protein levels are decreased in whole kidney lysates of Gpc3C/K and Bmp2C/K mutant mice (Fig. 3) . Immunoblot analysis demonstrated marked reductions in protein levels of BMP2 and GPC3, only in their respective mutant backgrounds. Because Bmp2 is an autosomal gene, each cell in the kidneys of Bmp2C/K mice will contain half the gene dosage of Bmp2. In contrast, Gpc3 is an X-linked gene. Therefore, it is expected that random X-inactivation of Gpc3 in Gpc3C/K heterozygotes will result in a mosaic pattern of GPC3 protein expression in these kidneys, with a mixture of GPC3-expressing and non-expressing cells. The recent demonstration that UB tip and trunk cells are nonclonal populations (Shakya et al., 2005) , suggests that GPC3-expressing and non-expressing cells in Gpc3C/K UBs will be randomly distributed within both the UB tip and trunk compartments. We evaluated the pattern of GPC3 expression in Gpc3C/K kidneys by immunohistochemistry (Fig. 4) . Using two independent monoclonal anti-GPC3 antibodies, our results show that GPC3 is ubiquitously expressed throughout the apical membrane and cytoplasm of UB cells at E13.5 in Wt and Bmp2C/K mice, consistent with its known expression pattern in non-renal cells (Capurro et al., 2003) . In contrast, we observed a mosaic pattern of GPC3 expression in Gpc3C/K kidneys, with UBs containing a heterogeneous population of randomly distributed, GPC3-expressing and non-expressing cells in both the tip and trunk regions of the UB. These results suggest that the effects of Gpc3 deficiency will be detectable in all segments of the UB, rather than being limited to specific regions within the UB. Fig. 3 . GPC3 and BMP2 expression are decreased in Gpc3C/K and Bmp2C/K mice, respectively. Representative immunoblot of GPC3 and BMP2 proteins taken from whole kidney lysates of Wt, Bmp2C/K and Gpc3C/K mice. GPC3 protein expression was decreased in the Gpc3C/K background compared to Wt and Bmp2C/K mutants. BMP2 protein expression was decreased in the Bmp2C/K background compared to Wt and Gpc3C/K mutants.
Next we examined whether genetic Gpc3-Bmp2 interactions control cell proliferation during embryonic kidney development (Fig. 5) . Our approach was identical to that used to determine the effects of Bmp2 and Smad4 on UB cell proliferation. UB cells were labeled with BrDU and imaged at both low and high power. Even at low power, an obvious and striking increase in the number of BrDU positive cells was detected in Gpc3C/K;Bmp2C/K kidneys (Fig. 5A) . At high power, modest increases in UB cell proliferation were detected in Gpc3C/K and Bmp2C/K kidneys in addition to the marked increase in UB cell proliferation observed in Gpc3C/K;Bmp2C/K mutants compared to Wt (Fig. 5B) . We confirmed these results using another cell proliferation marker, Ki67 (Fig. 5C ). We then quantitated UB cell proliferation in embryonic BrDU-labeled kidneys (Fig. 5D ). UB cell proliferation was increased in both Bmp2C/K (38% increase, PZ0.03) and Gpc3C/K (88% increase, PZ0.02) kidneys compared to Wt. However, in Gpc3C/K;Bmp2C/K double mutants, a striking increase in UB cell proliferation was observed compared to Wt (345%, PZ0.0002), Bmp2C/K (307%, PZ0.002), and Gpc3C/K mutants (257%, PZ0.01), an increase which was greater that the sum of that detected in the two single mutant groups.
Inspection of BrDU-labeled kidney tissue sections demonstrated an enlargement of the Gpc3C/K;Bmp2C/K kidneys compared to all other groups (Fig. 5A) . Similar to what we observed in Smad4C/K and Bmp2C/K ;Smad4C/K kidneys, it was also apparent that the increases in cell proliferation observed in Gpc3C/K;Bmp2C/K kidneys were not limited to the UB lineage, but extended to the mesenchymal compartment of the kidney (Fig. 5B,C) . We quantitated mesenchymal cell proliferation to determine whether these increases were statistically significant (Fig. 5E ). Our results demonstrate that mesenchymal cell proliferation was unchanged in Bmp2C/K and Gpc3C/K mutants compared to Wt, but was increased by approximately 50% in Gpc3C/K;Bmp2C/K mice compared to all other groups including Wt (55% increase, PZ0.02), Bmp2C/K (47% increase, PZ0.03) and Gpc3C/K mice (56% increase, PZ0.02). These results demonstrate that a single gene copy reduction of both Gpc3 and Bmp2 produces a defect in mesenchymal cell proliferation not observed in either single mutant alone. Further, our findings suggest that increases in mesenchymal cell proliferation contribute to the increased size of Gpc3C/K;Bmp2C/K kidneys, as we had previously demonstrated in Smad4C/K and Bmp2C/K;Smad4C/K kidneys. Since changes in cell proliferation may be accompanied by changes in apoptosis, we performed a TUNEL apoptosis assay in Bmp2C/K, Gpc3C/K, and Gpc3C/K; Bmp2C/K kidneys. However, in 3 separate experiments, we detected no difference in percent apoptosis in the kidneys of the mutant mice compared to those of Wt. Together with our observation that UB cell proliferation is enhanced in Gpc3C/K ;Bmp2C/K mutant kidneys to a level greater than that observed in both single mutants together, these results indicate that genetic interactions between Gpc3 and the Bmp2 signaling pathway control cell proliferation in both the UB and mesenchymal compartments during renal development in vivo.
Gpc3 modulates Bmp2-induced activation of phospho-SMAD1
Like other members of the TGF-b family, BMPs activate a SMAD signaling pathway [reviewed in (Shi and Massague, 2003) ]. Receptor-associated (R-) SMAD proteins which include SMAD1, 5 and 8, are the direct and specific substrates of the type I BMP receptor, and directly relay the BMP signal from the cell surface to target genes in the nucleus. In our previous work in collecting duct cells, we showed that phosphorylation of the R-SMAD, SMAD1 is required to propagate the inhibitory BMP2 signal during branching morphogenesis (Piscione et al., 2001) . To determine whether Gpc3 and Bmp2 function in a common pathway to control cell proliferation during branching morphogenesis, we examined the effects of Gpc3 and Bmp2 gene dosage on the level of phospho-SMAD1 expression in E13.5 kidneys in tissue sections and protein lysates (Fig. 6) . Phospho-SMAD1 expression, identified as brown nuclear staining in tissue sections, was not appreciably different in Gpc3C/K or Bmp2C/K compared to Wt, Fig. 4 . Mosaic expression pattern of GPC3 in Gpc3C/K embryonic kidneys. Immunohistochemistry using anti-GPC3 primary antibody demonstrates mosaic GPC3 expression in E13.5 Gpc3C/K embryonic kidneys. Red arrows denote UB trunks and black arrowheads denote UB tips. Strong expression of GPC3 was detected throughout the UB of Wt and Bmp2C/K embryonic kidneys (red membrane and cytoplasmic staining), while the negative control does not show any staining. In contrast, mosaic GPC3 expression was detected in UBs of Gpc3C/K kidneys, with GPC3 detected in some cells of the UB tips and trunks but undetectable in others. (*) denotes cells that express GPC3, ( †) denotes cells that do not express GPC3. Magnification: 400!. Bar: 50 mm. Fig. 5 . Genetic Gpc3-Bmp2 interactions control UB and mesenchymal cell proliferation. Cell proliferation was measured in paraffin-embedded E13.5 mouse kidney sections using an in situ BrDU incorporation assay, and stained with fluorescein-conjugated D. biflorus agglutinin (DBA) to identify UB/collecting duct branches. Kidney sections at both low (A) and high (B) magnification demonstrate the qualitative effects of Bmp2 and/or Gpc3 gene dosage on UB and mesenchymal cell proliferation, as indicated by dark red-colored nuclei. (A) At low magnification, a universal, robust increase in cell proliferation was observed in the Gpc3C/K;Bmp2C/K embryonic kidney compared to Wt, Bmp2C/K and Gpc3C/K groups. Magnification: 100!. Bar: 100 mm. (B) High magnification brightfield (BF) and immunofluorescence (IF) images highlight individual UBs of the same groups, as denoted by the black boxes in (A). At high power, a progressive increase in UB cell proliferation was observed in Bmp2C/K and Gpc3C/K kidneys compared to Wt. Notably, cell proliferation in both the UB and surrounding mesenchyme was markedly higher in Bmp2C/K;Gpc3C/K kidneys than in any other group. Magnification: 400!. Bar: 25 mm. (C) Qualitative effects of Bmp2 and/or Gpc3 gene dosage on UB and mesenchymal cell proliferation measured using anti-Ki67 antibody. Individual UBs are in either the UB or mesenchymal compartments. However, a striking and widespread diminution in nuclear phospho-SMAD1 expression was detected in Gpc3C/K;Bmp2C/K kidneys compared to all other groups (Fig. 6A) . This result was confirmed by analysis of phospho-SMAD1 expression in whole kidney protein lysates (Fig. 6B,C) . Phospho-SMAD1 was unaltered in Bmp2C/K kidneys, but was decreased 12% in Gpc3C/K mutants, and decreased by 38% in Gpc3C/K;Bmp2C/K mutants. Together, these results strongly implicate Gpc3 as a genetic modulator of the Bmp2 signaling axis, during renal development in vivo.
Renal branching morphogenesis, a process that is dependent upon reciprocal inductive interactions between the metanephric mesenchyme and epithelium-derived UB, is tightly regulated by both stimulatory and inhibitory factors. Several signaling pathways stimulate growth and branching of the UB in vivo. However, the inhibitory signaling pathways that control renal branching morphogenesis in vivo are largely undefined. We previously showed that exogenous application of BMP2 inhibits cell proliferation and branching in cultured kidney explants and in a collecting duct cell model of branching morphogenesis in vitro (Piscione et al., 1997) . Subsequently, we demonstrated that BMP2-mediated inhibition is abrogated in Fig. 6 . Phospho-SMAD1 expression was decreased in Gpc3C/K;Bmp2C/K E13.5 embryonic kidneys. (A) Immunohistochemistry using anti-phospho-SMAD1 primary antibody. Strong nuclear expression of phospho-SMAD1 was detected in both UB and mesenchymal compartments of Wt, Bmp2C/K and Gpc3C/K embryonic kidneys (brown-colored nuclei), but was reduced in both the UB and mesenchyme of Gpc3C/K;Bmp2C/K kidneys. Magnification: 400!. Bar: 50 mm. (B) Representative immunoblot of phospho-SMAD1 protein taken from pooled, E13.5 whole kidney lysates, with each lysates comprised of 2-3 pairs of kidneys from the same genetic group. A decrease in phospho-SMAD1 protein expression was observed in the Gpc3C/K;Bmp2C/K background compared to Wt, Bmp2C/K and Gpc3C/K groups. (C) Quantitation of phospho-SMAD1 protein expression from 2 independent immunoblots, representing a minimum of 4 kidneys per group. Phospho-SMAD1 expression was unaltered in Bmp2C/K embryonic kidneys, but was decreased 1.12-fold in Gpc3C/K kidneys, and 1.38-fold in Gpc3C/K;Bmp2C/K kidneys compared to Wt.
highlighted at high magnification. Red arrows denote the UB. Increases detected in cell proliferation in Bmp2C/K, Gpc3C/K and Gpc3C/K; Bmp2C/K kidneys (dark red-colored nuclei) closely parallel those observed using the in situ BrDU incorporation assay for the same groups (NZ3 experiments). Magnification: 400!. Bar: 25 mm. (D,E) Quantitation of UB (D) and mesenchymal (E) cell proliferation using an in situ BrDU incorporation assay. (D) UB cell proliferation was increased in Bmp2C/K, Gpc3C/K and Gpc3C/K;Bmp2C/K E13.5 embryonic kidneys compared to Wt (-fold increase: Bmp2C/K vs. Wt: 1.38G0.18, NZ7, PZ0.03, Gpc3C/K vs. Wt: 1.88G0.47, NZ7, PZ0.02, Gpc3C/K;Bmp2C/K vs. Wt: 4.45G0.58, NZ6, PZ0.0002). UB cell proliferation was not significantly different between BmpC/K and Gpc3C/K groups (-fold increase: Gpc3C/K vs. Bmp2C/K: 1.26G0.23, PZ0.36). In contrast, the increase in UB cell proliferation in Gpc3C/K;Bmp2C/K kidneys was significantly higher than both the Bmp2C/K and Gpc3C/K groups, and was greater than the combined additive effects of the 2 single mutant groups (-fold increase: Gpc3C/K;Bmp2C/K vs. Bmp2C/K: 3.07G0.38, PZ0.002, Gpc3C/K;Bmp2C/K vs. Gpc3C/K: 2.57G0.62, PZ0.01). NZnumber of complete kidney composites assessed. (E) Mesenchymal cell proliferation was unchanged in Bmp2C/K and Gpc3C/K mutants, but was increased in Gpc3C/K;Bmp2C/K mutants compared to Wt. and to both single mutant groups (-fold increase: Gpc3C/K;Bmp2C/K vs. Wt: 1.55G0.18, PZ0.02, Gpc3C/K;Bmp2C/K vs. Bmp2C/K: 1.47G0.10, PZ0.03, Gpc3C/K;Bmp2C/K vs. Gpc3C/K: 1.56G0.11, PZ0.02).
cultured kidney explants isolated from GPC3 deficient embryos (Grisaru et al., 2001) . Here, we show that UB cell proliferation is increased in Bmp2C/K and Gpc3C/K embryonic kidneys. Moreover, we observed a marked increase in UB cell proliferation in Gpc3C/K;Bmp2C/K kidneys that was greater than the sum of that observed in Gpc3C/K and Bmp2C/K single mutants. Further, we demonstrate that mesenchymal cell proliferation is increased in Gpc3C/K;Bmp2C/K mutants, a defect that is not observed in either parental strain. Together with our observation that the level of the BMP2 effector phospho-SMAD1 is unchanged in Bmp2C/K and Gpc3C/K mutants, but is markedly decreased in Gpc3C/K;Bmp2C/K kidneys, these results provide the first genetic evidence that an inhibitory Bmp2 signaling pathway controls UB cell proliferation and branching during renal branching morphogenesis in vivo, and that Bmp2 signaling is genetically modulated by GPC3. Studies in flies and in non-renal tissues in mice provided the first clues that Gpc3 function is linked to Bmp activity during development in vivo. In flies, abnormal morphogenesis of the eye and wing in dally (glypican orthologue) mutants is due in part to loss of cellular responses to the Bmp orthologue decapentaplegic (Nakato et al., 1995; Jackson et al., 1997; Fujise et al., 2003) . In mice, Gpc3-Bmp4 interactions control limb patterning and skeletal development in vivo (Paine-Saunders et al., 2000) . Novel, severe defects restricted to the appendicular and axial skeleton are observed in Gpc3K/;Bmp4C/K compound mutants with high penetrance, reflecting the highly tissuespecific nature of Gpc3-Bmp interactions during development. While the molecular basis of Bmp2-Gpc3 interactions during mammalian development remain undefined, our results, together with these studies in flies and in nonrenal tissue in mice, suggest that a primary and evolutionarily conserved function of Gpc3 is to regulate Bmp signaling during development in vivo.
Experimental procedures
3.1. Generation of mice, gender determination and genotyping Bmp2C/K mice (C57BL/6) were kindly provided by Dr P. Labosky (U. Pennsylvania), and Smad4C/K mice (C57BL/6) were kindly provided by Dr T. Mak (U. Toronto). Bmp2C/K and Smad4C/K mice were crossed to generate Bmp2C/K;Smad4C/K offspring. Pups and embryos were genotyped by PCR using primers specific for the null alleles of Bmp2 and Smad4 (Smad4, 5 0 -AGCTTGTCTTTTAGGTGATTG-3 0 ; 5 0 -GGAAGAACT-TATGATTAGGAA-3 0 ; Bmp2 (5 0 -GTGACATTAGGCTG CTGTAGCA-3 0 ; 5 0 -GAGACTAGTGAGACGTGCTACT-3 0 ; 5 0 -AGCATGAACCCTCATGTGTTGG-3 0 ) as previously described (Sirard et al., 1998; Zhang and Bradley, 1996) . Gender determination was performed by PCR, using sex-determining region Y (Sry)-specific primers to identify males (5 0 -TGGCGATTAAGTCAAATTCGC-3 0 ; 5 0 -CCC CCTAGTACCCTGACAATGTATT-3 0 ) as previously described (Lo et al., 1998) .
Gpc3C/K females (C57BL/6) were crossed with Bmp2C/K males (C57BL/6) to generate female Gpc3C /K;Bmp2C/K offspring. Female Gpc3C/K heterozygotes were distinguished from male Gpc3K/ homozygotes using PCR, by the presence of both the wild type and null alleles of Gpc3 (wild type:
0 ), as previously described (Cano-Gauci et al., 1999) .
Assessment of ureteric bud branching
Kidneys were surgically dissected from E13.5 pregnant mice and fixed with 4% formaldehyde in PBS. UB-derived structures were identified in whole-mount kidney specimens with fluorescein isothiocyanate (FITC)-conjugated Dolichos Biflorus agglutinin (DBA) (20 mg/ml; Vector Labs, CA). UB branch points were defined as the intersection between three connected branches as previously described (Grisaru et al., 2001 ).
In situ cell proliferation assay
UB cell proliferation in embryonic kidneys was assayed using 5-bromo-2 0 deoxyuridine (BrDU), as previously described (Cano-Gauci et al., 1999) . Briefly, pregnant mice were injected with BrDU, and embryonic kidneys were surgically dissected 4 h later. Kidneys were fixed with 4% formaldehyde in PBS, and sectioned (4 mm). Tissue sections were treated with 0.01% pepsin in 10 mM HCl for 30 min at 37 8C, acid-denatured in 2 N HCl for 45 min, and neutralized in 0.1 M Borax for 10 min. After blocking with normal goat serum (3% BSA, Sigma) for 1 h at room temperature, sections were incubated with peroxidase-conjugated antiBrDU antibody (Roche, QC) at 4 8C overnight and at a dilution of 1:20. Staining was visualized using peroxidase substrate aminoethyl carbazole (AEC) (Zymed Labs, CA).
To quantitate UB cell proliferation for each kidney sample, the entire kidney section was imaged in overlapping fields at high power (400!magnification), and a digital composite image of each kidney section was then constructed. UB cell proliferation was calculated as the ratio of BrDU-positive UB cells to total number of UB cells in each complete kidney composite. Each kidney sample (N) thus represents a high-resolution, 2-dimensional composite image of a whole kidney section. In order to standardize for differences in cell proliferation between litters, and in absolute BrDU incorporation which varied considerably from litter to litter, the % BrDU incorporation calculated for each mutant sample in a given litter was subsequently recalculated as a ratio to that of its Wt littermate(s). BrDU ratios from samples from different litters were then grouped together by genotype, with values presented as -fold increases over Wt.
Standardization and quantitation of mesenchymal cell proliferation
The same complete kidney composites used to calculate UB BrDU incorporation were used to determine mesenchymal cell proliferation. Thus each kidney sample (N) represents a complete kidney composite image assayed for mesenchymal BrDU incorporation. Mesenchymal cell proliferation was first standardized to tissue section size by expressing mesenchymal cell proliferation as the ratio of BrDU-positive mesenchymal cells to total tissue surface area. This was accomplished by overlaying each digital kidney composite image with a grid, and counting the number of boxes filled by each kidney section. Mesenchymal cell proliferation was quantitated as the ratio of BrDUpositive cells, DBA-negative cells to total number of filled boxes in the grid.
Immunohistochemistry and western blot analysis
In experiments using anti-Ki67 and anti-phospho-SMAD1 antibodies, paraffin wax-embedded sections (4 mm) of embryonic kidney tissue were pre-treated by microwave heating in 10 mM sodium citrate buffer (pH 6.0) in a microwave pressure cooker 20 min, including 3 min of fully-pressurized boiling, and allowed to cool for 30 min. After a 15-min incubation in 1% H 2 0 2 to quench endogenous peroxidase activity, tissue sections were incubated in normal goat serum (3% BSA, Sigma) for 1 h at room temperature, followed by incubation with primary polyclonal antibody (anti-phospho-SMAD1: 1:10 dilution, Cell Signaling Tech, MA; anti-Ki67: 1:200 dilution, ABCAM, MA) at 4 8C overnight. Sections were incubated in biotinylated goat antirabbit secondary antibody (1:100, Vector labs, CA) for 1 h at room temperature, ABC-complexed (ABC Elite kit, Vector labs, CA), and stained with AEC (Zymed Labs, CA). Negative controls were incubated with normal rabbit serum (Upstate, USA) instead of primary antibody.
In experiments using anti-GPC3 antibody, paraffin waxembedded sections (4 mm) of embryonic kidney tissue were pre-treated by microwave heating in 10 mM sodium citrate buffer (pH6.0) in a microwave pressure cooker for 15 min, including 1.5 min of fully-pressurized boiling before being allowed to cool for 30 min. After a 15-min incubation in 1% H 2 0 2 , tissue sections were incubated in M.O.M. (Vector labs, CA) blocking solution for 1 h at room temperature, followed by incubation with anti-GPC3 primary antibody (1:200 dilution, 1G-12 and 8H-5 mouse monoclonal antibodies, a kind gift from Biomosaics, VT) at 4 8C overnight. Sections were incubated in biotinylated M.O.M. anti-mouse secondary antibody (1:100, Vector labs, CA) for 30 min at room temperature, ABC-complexed (ABC Elite kit, Vector labs, CA), and stained with AEC (Zymed Labs, CA). Negative controls were incubated with pure mouse IgG (Upstate, USA) instead of primary antibody.
For immunoblotting of tissue lysates, kidneys were surgically dissected from E13.5 pregnant mice and stored as kidney pairs at K80 8C. For each of the 4 genetic groups (Wt, Bmp2C/K, Gpc3C/K, Bmp2C/K; Gpc3C/K), 2-3 pairs of kidneys were pooled together in a single microcentrifuge tube, homogenized in 100 mL of RIPA buffer using a Kontes mini-homogenizer (Kontes Glass Co, Vineland, NJ), and sonicated. Protein lysates were separated by SDS-PAGE and transferred onto a polyvinylidene difluoride membrane, and incubated with primary antibody at 4 8C overnight. Primary antibodies were used at the following dilutions: Anti-phospho-SMAD1: 1:150, anti-GPC3: 1:200, anti-BMP2: 1:150 (Santa Cruz, CA). Chemiluminescence was performed using a commercial ECL reagent kit (Amersham Pharmacia Biotech, NJ).
Statistical analysis
Values are presented as the mean differencesGSE computed from pooled data. Mean differences were examined using a Student's t-test (two-tailed). Significance was taken at a value of P!0.05. For branching assays, N represents the number of whole kidney explants analyzed; for cell proliferation assays, N represents the number of whole digital kidney composite images analyzed.
